HIV 1 News and Research

RSS

Online reference library provides a more accurate picture of drug exposure

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at medical records. But this information is often incomplete.

9 Dec 2025

Long-acting HIV treatment could improve outcomes for breastfeeding women

Sujata Tewari, BA, previously of the Medical Practice Evaluation Center (MPEC) at Massachusetts General Hospital, and Andrea L. Ciaranello, MD, MPH, of the MPEC and Department of Medicine at Massachusetts General Hospital, are the lead and senior authors of a paper published in the Journal of Infectious Diseases, “Long-acting antiretroviral therapy for breastfeeding women with HIV experiencing barriers to adherence in Zimbabwe: Modeling clinical impact and cost-effectiveness.

4 Dec 2025

New rapid test distinguishes real HIV infections from vaccine-related false positives

Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have contracted the virus and an additional 44.1 million have died from related causes.

3 Dec 2025

New investment aims to accelerate treatments for low-grade brain tumors

Researchers focused on accelerating and testing new treatments for low-grade brain tumors are set to receive a transformative £2.8 million to drive their future work.

3 Dec 2025

Medical cannabis evidence falls short for most conditions

Medical cannabis lacks adequate scientific backing for most of the conditions it is commonly used to treat, including chronic pain, anxiety and insomnia, according to a comprehensive review led by UCLA Health.

3 Dec 2025

Common water pill may be a useful add‑on to the standard HIV treatment

An FDA‑approved medication called spironolactone, often prescribed as a diuretic, or water pill, for heart and blood pressure conditions, may be a useful add‑on to the standard HIV treatment, according to new research from the Valente lab at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology.

2 Dec 2025

WHO urges action to end the AIDS epidemic

On World AIDS Day, the World Health Organization (WHO) calls on governments and partners to rapidly expand access to new WHO-approved tools including lenacapavir (LEN) to drive down infections and counter disruption to essential health services caused by cuts to foreign aid.

2 Dec 2025

RFK Jr. wants to delay the hepatitis B vaccine. Here’s what parents need to know.

Working out of a tribal-owned hospital in Anchorage, Alaska, liver specialist Brian McMahon has spent decades treating the long shadow of hepatitis B. Before a vaccine became available in the 1980s, he saw the virus claim young lives in western Alaskan communities with stunning speed.

2 Dec 2025

Research says global HIV efforts need renewed funding and focus

As the world marks World AIDS Day on Dec. 1, world-renowned infectious disease expert Anthony Fauci, MD, and his colleague Greg Folkers, MS, MPH, highlight advances made in the treatment and prevention of HIV that could finally end the pandemic, but caution, "History will judge us harshly should we squander this opportunity."

1 Dec 2025

Killer T cell traits explain why some people achieve long-term HIV remission after treatment

Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV who are given a treatment called broadly neutralizing anti-HIV antibodies (bNAbs) can safely stop taking standard, lifelong HIV medications and maintain control of the virus for years, while others given the same treatment do not achieve this remission.

1 Dec 2025

Combination immunotherapy may be the key to control HIV without long-term antiviral treatment

A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment - an advance that points the way toward a possible cure for a disease that affects 40 million people around the world.

1 Dec 2025

Updated Canadian guideline aims to raise awareness of new HIV prevention strategies

Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated Canadian guideline published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250511 contains 31 recommendations and 10 good practice statements to help clinicians and other health care professionals offer these safe and effective options to teen and adult patients.

1 Dec 2025

Late HIV diagnoses threaten Europe’s progress toward ending AIDS by 2030

Europe is failing to test and treat HIV early, with over half (54%) of all diagnoses in 2024 being made too late for optimal treatment.

27 Nov 2025

'Mental model' approach shown to reduce effects of misinformation about mRNA vaccines

Correcting misinformation after it has gone viral is a common way of informing the public that what they've encountered may be inaccurate, lack context, be unproven, or be demonstrably false.

24 Nov 2025

Study uncovers how a specific immune cell may contribute to HIV persistence

Researchers from the Institute of Human Virology (IHV) at the University of Maryland School of Medicine have discovered how a specific type of immune cell may contribute to the persistence of HIV infections.

24 Nov 2025

New analysis shows one in two people in the U.S. live with neurological conditions

One in two people in the United States, just over half of the population, is affected by a neurological disease or disorder, according to a new systematic analysis by the American Academy of Neurology and the Institute for Health Metrics and Evaluation published on November 24, 2025, in the journal JAMA Neurology.

24 Nov 2025

Increasing resistance to key gonorrhea antibiotics raises alarm

The World Health Organization (WHO) warns that gonorrhea, a sexually transmitted infection, is becoming increasingly resistant to antibiotics, according to new data from its Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), which monitors the spread of drug-resistant gonorrhea.

19 Nov 2025

New AI investment aims to accelerate the search for an effective HIV vaccine

As of 2024, over 40 million people in the world are diagnosed with human immunodeficiency virus (HIV)-a chronic, life-threatening infection that remains one of the leading global causes of death.

18 Nov 2025

Medicaid expansion boosts PrEP access for people at risk of HIV diagnosis

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable form, according to Rutgers Health–led research.

17 Nov 2025

Funding challenges threaten to reverse global gains in the fight against TB

Tuberculosis (TB) remains one of the world's deadliest infectious killers, claiming over 1.2 million lives and affecting an estimated 10.7 million people last year, according to the WHO Global Tuberculosis Report 2025, released today.

13 Nov 2025

HIV 1 News and Research

Online reference library provides a more accurate picture of drug exposure

Long-acting HIV treatment could improve outcomes for breastfeeding women

New rapid test distinguishes real HIV infections from vaccine-related false positives

New investment aims to accelerate treatments for low-grade brain tumors

Medical cannabis evidence falls short for most conditions

Common water pill may be a useful add‑on to the standard HIV treatment

WHO urges action to end the AIDS epidemic

RFK Jr. wants to delay the hepatitis B vaccine. Here’s what parents need to know.

Research says global HIV efforts need renewed funding and focus

Killer T cell traits explain why some people achieve long-term HIV remission after treatment

Combination immunotherapy may be the key to control HIV without long-term antiviral treatment

Updated Canadian guideline aims to raise awareness of new HIV prevention strategies

Late HIV diagnoses threaten Europe’s progress toward ending AIDS by 2030

'Mental model' approach shown to reduce effects of misinformation about mRNA vaccines

Study uncovers how a specific immune cell may contribute to HIV persistence

New analysis shows one in two people in the U.S. live with neurological conditions

Increasing resistance to key gonorrhea antibiotics raises alarm

New AI investment aims to accelerate the search for an effective HIV vaccine

Medicaid expansion boosts PrEP access for people at risk of HIV diagnosis

Funding challenges threaten to reverse global gains in the fight against TB

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News